The second leading cause of new cancer cases in men worldwide with over two million sufferers in the US alone, prostate cancer is typically a disease that affects older men and is thus on the increase as global life expectancies continue to rise. It is also one of the largest sectors of the pharmaceutical oncology industry. Expertly formulated reports in this section will help you to formulate effective market strategies by answering key questions such as who are the main and key niche players, what
are the new drugs and therapies (including vaccines and therapeutic antibodies) in the pipeline, and what are the latest areas of pharmaceutical R&D. Manufacturers will find multiple report options to assist them in assessing competition and market opportunities.